Corcept Therapeutics Incorporated (CORT) Balance Sheet
As of 2026-06-30 (10-Q), Corcept Therapeutics Incorporated (CORT) reported total assets of $888.7M, total liabilities of $182.9M and shareholders' equity of $705.8M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $112.3M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CORTCorcept Therapeutics IncorporatedFollow CORT — free
—
Price chart with a free account
- Market cap
- 9.3B
- P/E TTM
- 204.4
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 39.6 | 93.0 | 54.9 | 24.2 | 40.4 | 51.5 | 31.1 | 41.6 | 31.3 | 76.2 | 77.6 | 66.3 | 135.6 | 128.7 | 121.7 | 112.3 | |
| Short-term investments | — | — | — | — | — | 0.0 | 57.7 | 165.1 | 244.7 | 364.5 | 145.9 | 365.3 | 232.7 | 255.7 | 251.7 | 197.2 | |
| Receivables | — | 0.6 | 1.4 | 3.3 | 6.2 | 9.9 | 15.3 | 17.6 | 19.9 | 26.2 | 27.6 | 31.1 | 41.1 | 54.0 | 59.8 | 76.9 | |
| Inventory | — | 0.9 | 1.1 | 1.2 | 1.7 | 2.3 | 4.6 | 4.7 | 5.4 | 4.9 | 5.0 | 6.1 | 7.7 | 12.4 | 12.9 | 13.2 | |
| Current assets | 39.8 | 95.1 | 58.3 | 30.2 | 49.0 | 65.7 | 124.2 | 236.8 | 307.4 | 478.5 | 266.5 | 499.3 | 458.6 | 471.6 | 485.5 | 439.7 | |
| Total assets | 39.8 | 99.2 | 63.1 | 34.6 | 51.9 | 68.8 | 220.5 | 311.7 | 412.3 | 571.7 | 423.8 | 583.4 | 621.5 | 840.6 | 836.7 | 888.7 | |
| Current liabilities | 5.0 | 8.4 | 12.7 | 13.6 | 20.9 | 27.4 | 29.6 | 35.6 | 38.8 | 47.5 | 47.5 | 72.5 | 104.5 | 140.8 | 166.1 | 153.8 | |
| Long-term debt | — | 29.0 | 29.3 | 24.5 | 12.5 | 0.0 | 0.0 | — | — | — | — | — | — | — | — | — | |
| Short-term debt | — | 2.7 | 5.7 | 9.4 | 15.0 | 14.7 | 0.0 | — | — | — | — | — | — | — | — | — | |
| Total liabilities | — | — | — | — | — | — | 29.6 | 35.8 | 41.1 | 48.4 | 48.0 | 81.6 | 114.8 | 161.0 | 188.8 | 182.9 | |
| Shareholders' equity | 34.8 | 61.8 | 21.0 | -3.4 | 18.5 | 41.4 | 191.0 | 275.9 | 371.2 | 523.3 | 375.8 | 501.8 | 506.7 | 679.6 | 647.8 | 705.8 |
USD millions · SEC XBRL
Corcept Therapeutics Incorporated — questions
- How much cash does Corcept Therapeutics Incorporated have?
- $112.3M in cash and cash equivalents as of 2026-06-30.
- What are Corcept Therapeutics Incorporated's total assets?
- $888.7M as of 2026-06-30.
- What is Corcept Therapeutics Incorporated's shareholders' equity?
- $705.8M as of 2026-06-30.
Every figure on this page comes from Corcept Therapeutics Incorporated's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.